Hurley Capital’s Olema Oncology OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
SL
Hurley Capital's OLMA Position: Q3 2026 in Review
Hurley Capital held its Olema Oncology (OLMA) position steady in Q3 2026 at 29 shares worth $251. The position accounts for ﹤0.01% of the portfolio, ranked #624.
Hurley Capital first reported a position in OLMA in Q4 2025 and has held it in 4 quarters since. The position peaked at $725 in Q4 2025. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.
- Hurley Capital held 29 shares of Olema Oncology worth $251 as of Q3 2026.
- Hurley Capital left its Olema Oncology share count unchanged in Q3 2026.
- Olema Oncology made up ﹤0.01% of Hurley Capital's portfolio in Q3 2026, its #624 holding.
- Hurley Capital first reported a position in Olema Oncology in Q4 2025 and has held it in 4 quarters since.
- Hurley Capital's Olema Oncology position peaked at $725 in Q4 2025.
- 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.
Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.